PGNY Progyny Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGNY

Price (delayed)

$36.45

Market cap

$3.49B

P/E Ratio

65.09

Dividend/share

N/A

EPS

$0.56

Enterprise value

$3.35B

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously ...

Highlights
Progyny's gross profit has surged by 53% YoY and by 8% QoQ
PGNY's equity is up by 49% year-on-year and by 10% since the previous quarter
The company's debt has surged by 163% YoY but it fell by 2.4% QoQ
Sector: Healthcare
Industry: Health Information Services
Website: http://www.progyny.com

Key stats

What are the main financial stats of PGNY
Market
Shares outstanding
95.84M
Market cap
$3.49B
Enterprise value
$3.35B
Valuations
Price to earnings (P/E)
65.09
Price to book (P/B)
6.75
Price to sales (P/S)
3.37
EV/EBIT
60.47
EV/EBITDA
58.27
EV/Sales
3.25
Earnings
Revenue
$1.03B
EBIT
$55.45M
EBITDA
$57.54M
Free cash flow
$198.99M
Per share
EPS
$0.56
Free cash flow per share
$2.08
Book value per share
$5.4
Revenue per share
$10.82
TBVPS
$7.48
Balance sheet
Total assets
$726.51M
Total liabilities
$211.12M
Debt
$17.7M
Equity
$515.39M
Working capital
$417.85M
Liquidity
Debt to equity
0.03
Current ratio
3.16
Quick ratio
3.12
Net debt/EBITDA
-2.44
Margins
EBITDA margin
5.6%
Gross margin
21.9%
Net margin
5%
Operating margin
5%
Efficiency
Return on assets
8%
Return on equity
11.6%
Return on invested capital
17.7%
Return on capital employed
10.4%
Return on sales
5.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGNY stock price

How has the Progyny stock price performed over time
Intraday
3.11%
1 week
7.24%
1 month
18.23%
1 year
13.98%
YTD
17.01%
QTD
7.14%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$1.03B
Gross profit
$226.4M
Operating income
$51.69M
Net income
$51.98M
Gross margin
21.9%
Net margin
5%
Progyny's operating income has surged by 160% YoY and by 15% QoQ
PGNY's operating margin has surged by 79% year-on-year and by 6% since the previous quarter
Progyny's gross profit has surged by 53% YoY and by 8% QoQ
The revenue is up by 48% year-on-year and by 8% since the previous quarter

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
PGNY P/E details
P/E
65.09
P/B
6.75
P/S
3.37
EV/EBIT
60.47
EV/EBITDA
58.27
EV/Sales
3.25
The EPS has grown by 22% year-on-year and by 6% since the previous quarter
The stock's price to earnings (P/E) is 13% less than its last 4 quarters average of 74.4
PGNY's price to book (P/B) is 56% lower than its 5-year quarterly average of 15.4 and 6% lower than its last 4 quarters average of 7.2
PGNY's equity is up by 49% year-on-year and by 10% since the previous quarter
PGNY's price to sales (P/S) is 50% lower than its 5-year quarterly average of 6.8 and 3.7% lower than its last 4 quarters average of 3.5
The revenue is up by 48% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Progyny business performance
PGNY's return on invested capital has surged by 113% year-on-year and by 9% since the previous quarter
The return on sales has surged by 93% year-on-year and by 10% since the previous quarter
The company's return on equity fell by 18% YoY and by 4.9% QoQ
Progyny's return on assets has decreased by 17% YoY and by 3.6% QoQ

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
PGNY's total assets is up by 42% YoY and by 7% from the previous quarter
PGNY's total liabilities is up by 29% year-on-year
The company's debt is 97% lower than its equity
The company's debt has surged by 163% YoY but it fell by 2.4% QoQ
PGNY's debt to equity has surged by 50% year-on-year but it is down by 25% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.